Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,273 recalls, newest first

Class I · High risk

Rose Medical Center

Non-Sterility: Out of specification results for the sterility test for microbial contamination.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-440-2015
Class I · High risk

Rose Medical Center

Non-Sterility: Out of specification results for the sterility test for microbial contamination.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. D-439-2015
Class II · Moderate risk

J-TAN D PD Drops

Labeling: Not Elsewhere Classified: Product is labeled "Dye Free" on front panel but contains Red Dye 40.

Terminated Labeling / mix-up Jaymac Pharmaceuticals L.L.C. D-0327-2015
Class II · Moderate risk

Gabapentin Capsules

Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

Terminated Failed specification Actavis Elizabeth LLC NDC 45963-555-11 D-0338-2015
Class II · Moderate risk

Gabapentin Capsules

Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

Terminated Failed specification Actavis Elizabeth LLC NDC 45963-556-11 D-0337-2015
Class II · Moderate risk

Gabapentin Capsules

Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

Terminated Failed specification Actavis Elizabeth LLC NDC 14550-513-02 D-0336-2015
Class I · High risk

Professional Formexx Black

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0990-2015
Class I · High risk

Swoll-250 Super Mass Builder Quad Stack

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0989-2015
Class I · High risk

Estrastain Pro-Anabolic Mass and Hardening Complex

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0988-2015
Class I · High risk

7-Ment Alpha Advanced Mass Builder

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0987-2015
Class I · High risk

Halo-70 Mega Mass Builder

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0986-2015
Class I · High risk

M14-Ment Advanced Mass Builder

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0985-2015
Class I · High risk

M1-Alpha Labs Mega Mass Builder

Marketed without an approved NDA/ANDA - These products are being recalled due to the presence of synthetic hormone/prohormone (methylated anabolic steroid) ingredient making them unapproved new drugs.

Terminated Unapproved drug Anabolic Science Labs, LLC D-0984-2015
Class II · Moderate risk

Glutathione 200 mg/mL Injectable

Incorrect Product Formulation: An incorrect gas was used to remove the oxygen from the vial.

Terminated cGMP deviation Right Value Drug Stores, Inc. D-0335-2015
Class III · Low risk

sulfur8

Failed pH specification: Product pH test value of 5.72 failed to meet its product specification of 6.0 to 7.5.

Terminated Failed specification J. Strickland and Co D-0318-2015
Class III · Low risk

BELVIQ¿ (Lorcaserin HCl)

Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.

Terminated Labeling / mix-up Eisai Inc D-0302-2015
Class III · Low risk

Fluoxetine Capsules USP

Labeling: Illegible Label: Sandoz Inc. is recalling of one lot of Fluoxetine Capsules due to an illegible logo on the capsule.

Terminated Labeling / mix-up Sandoz Incorporated NDC 0781-2822-01 D-0291-2015
Class I · High risk

0.9% Sodium Chloride Injection USP

Presence of Particulate Matter: Confirmed customer complaints received for the presence of blue plastic, identified as fragments of the frangible from the vial adapter.

Terminated Particulate / foreign matter Baxter Healthcare Corp NDC 0338-0553-18 D-481-2015

Recalls by year